Follow Us On
Tablet
Files
Ranolazine ER
Strength: 500mg
Count: 50
NDC
50268-722-15
Class
Rx
Brand Name
Ranexa Extended-Release
Imprint Code
A47;500
Color(s)
Orange
Shape
Oval (oval shaped biconvex)
Score
No Score
Case Count
NA
Inactive Ingredients
colloidal silicon dioxide, hypromellose, iron oxide yellow, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium hydroxide, talc, titanium dioxide and additional inactive ingredients for the 500 mg tablet include iron oxide red.
Indications and Usage
Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti- platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers
